Automated And Closed Cell Therapy Processing System Market Research Report By Cell Therapy (CAR T-Cell Therapies, TCR Gene-Edited Cell Therapies, NK Cell Therapies), By Application (Oncology, Hematology, Immunology, Neurology), By System Capability (Single-Use, Multi-Use, Closed, Semi-Closed, Open), By Scale of Production (Benchtop, Pilot Scale, Commercial Scale), By Device Type (Cell Isolators, Cell Expanders, Cell Culture Vessels, Cell Dispensers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)

Automated And Closed Cell Therapy Processing System Market Overview:

As per MRFR analysis, the Automated And Closed Cell Therapy Processing System Market Size was estimated at 0.94 (USD Billion) in 2022. The Automated And Closed Cell Therapy Processing System Market Industry is expected to grow from 1.04(USD Billion) in 2023 to 2.5 (USD Billion) by 2032. The Automated And Closed Cell Therapy Processing System Market CAGR (growth rate) is expected to be around 10.29% during the forecast period (2024 - 2032).

Key Automated And Closed Cell Therapy Processing System Market Trends Highlighted

Key market drivers for automated and closed cell therapy processing systems include the growing prevalence of chronic diseases, advancements in cellular therapies, and increasing research and development in the field.Opportunities to be explored include the development of new and more efficient systems, the integration of artificial intelligence and machine learning, and the expansion of applications into new therapeutic areas.Recent trends in the market include the adoption of single-use technologies, the focus on reducing costs and improving efficiency, and the emphasis on patient safety and regulatory compliance. These trends are expected to continue to shape the market in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Automated And Closed Cell Therapy Processing System Market Drivers

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and genetic disorders, is a major driver of the Automated And Closed Cell Therapy Processing System Market Industry. These diseases require advanced and personalized treatment approaches, and cell therapy has emerged as a promising solution. Automated and closed cell therapy processing systems enable the efficient and scalable production of cell-based therapies, making them more accessible to patients.

Technological Advancements

Technological advancements are another key driver of the Automated And Closed Cell Therapy Processing System Market Industry. The development of new technologies, such as gene editing and CAR T-cell therapies, has expanded the potential applications of cell therapy. Automated and closed cell therapy processing systems facilitate the implementation of these advanced technologies, ensuring the safety and consistency of the manufacturing process.

Government Support and Funding

Government support and funding play a significant role in the growth of the Automated And Closed Cell Therapy Processing System Market Industry. Governments worldwide are recognizing the potential of cell therapy and are investing in research, development, and infrastructure. This support has helped to accelerate the development and commercialization of automated and closed cell therapy processing systems.

Automated And Closed Cell Therapy Processing System Market Segment Insights:

Automated And Closed Cell Therapy Processing System Market Cell Therapy Insights

The market growth is attributed to the increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in cell therapy. Cell Therapy segment is expected to witness significant growth owing to the rising adoption of CAR T-Cell Therapies, TCR Gene-Edited Cell Therapies, and NK Cell Therapies. CAR T-Cell Therapies have shown promising results in treating hematologic malignancies, and their use is expected to expand in the coming years. TCR Gene-Edited Cell Therapies are also gaining traction due to their ability to target specific antigens and provide durable responses.NK Cell Therapies are being explored for their potential in treating various cancers and immune disorders. The Automated And Closed Cell Therapy Processing System Market is highly competitive, with several key players operating in the market. These players are focusing on developing innovative products and technologies to gain a competitive edge. The market is also witnessing a trend towards consolidation, with larger players acquiring smaller companies to expand their portfolio and geographic reach.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Automated And Closed Cell Therapy Processing System Market Application Insights

The Automated And Closed Cell Therapy Processing System Market is segmented by Application into Oncology, Hematology, Immunology, and Neurology. The Oncology segment is expected to hold the largest share of the market in 2023, owing to the increasing prevalence of cancer and the growing demand for personalized cancer treatments. The Hematology segment is also expected to witness significant growth due to the rising incidence of blood-related disorders and the growing adoption of cell-based therapies. The Immunology and Neurology segments are expected to grow at a steady pace, driven by the increasing demand for therapies for autoimmune diseases and neurological disorders.

Automated And Closed Cell Therapy Processing System Market System Capability Insights

The System Capability segment of the Automated And Closed Cell Therapy Processing System Market can be categorized into Single-Use, Multi-Use, Closed, Semi-Closed, and Open systems. Among these, Single-Use systems held the largest market share in 2023, accounting for around 55% of the Automated And Closed Cell Therapy Processing System Market revenue. The increasing adoption of Single-Use systems can be attributed to their advantages, such as reduced risk of cross-contamination, improved safety, and ease of operation. Multi-Use systems are expected to witness significant growth over the forecast period, owing to their lower cost and higher flexibility compared to Single-Use systems.Closed systems offer a sterile and controlled environment for cell therapy processing, which is expected to drive their demand in the coming years. Semi-Closed and Open systems are also expected to contribute to the growth of the Automated And Closed Cell Therapy Processing System Market, albeit at a slower pace.

Automated And Closed Cell Therapy Processing System Market Scale of Production Insights

The Automated And Closed Cell Therapy Processing System Market is segmented by scale of production into benchtop, pilot scale, and commercial scale. The commercial scale segment is expected to hold the largest share of the market in 2023, accounting for over 50% of the Automated And Closed Cell Therapy Processing System Market revenue. This is due to the increasing demand for automated and closed cell therapy processing systems from large-scale cell therapy manufacturers. The pilot scale segment is expected to grow at the highest CAGR during the forecast period, owing to the increasing adoption of pilot-scale systems for process development and optimization.The benchtop segment is expected to account for a small share of the market, as it is primarily used for research and development purposes.

Automated And Closed Cell Therapy Processing System Market Device Type Insights

The Device Type segment of the Automated And Closed Cell Therapy Processing System Market is projected to witness significant growth over the forecast period, driven by the increasing demand for cell-based therapies and the need for efficient and automated cell processing systems. Within the Device Type segment, Cell Isolators are expected to account for a significant share of the market, owing to their critical role in isolating target cells from complex biological samples. Cell Expanders are also anticipated to gain traction due to their ability to expand cell populations ex vivo, which is essential for cell therapy applications. Cell Culture Vessels and Cell Dispensers are other key components of the Device Type segment, contributing to the overall market growth. The Automated And Closed Cell Therapy Processing System Market revenue is expected to reach USD 1.2 billion by 2024, with a CAGR of 10.29% during the forecast period. Segmentation insights like these are crucial for market players to understand the specific dynamics of different segments and tailor their strategies accordingly.

Automated And Closed Cell Therapy Processing System Market Regional Insights

North America is expected to account for the largest share of the market in 2023, and is expected to continue to dominate the market over the forecast period. This is due to the increasing adoption of automated and closed cell therapy processing systems in the region, as well as the presence of major market players in the region. Europe is expected to account for the second largest market share in 2023, and is expected to grow at a CAGR of around 10.5% over the forecast period. This is due to the increasing demand for automated and closed cell therapy processing systems in the region, as well as the presence of major market players in the region.Asia Pacific is expected to account for the third largest market share in 2023, and is expected to grow at a CAGR of around 11.0% over the forecast period. This is due to the increasing demand for automated and closed cell therapy processing systems in the region, as well as the presence of major market players in the region. South America and the Middle East and Africa are expected to account for the smallest market share in 2023, and are expected to grow at a CAGR of around 10.0% and 10.5%, respectively, over the forecast period.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Automated And Closed Cell Therapy Processing System Market Key Players And Competitive Insights:

Major players in Automated And Closed Cell Therapy Processing System Market industry are consistently striving to enhance their product portfolios and expand their global presence. Leading Automated And Closed Cell Therapy Processing System Market players are actively involved in strategic collaborations, mergers, and acquisitions to gain a competitive edge. The Automated And Closed Cell Therapy Processing System Market industry is characterized by intense competition among established players, as well as emerging startups that are introducing innovative technologies and solutions. The competitive landscape is expected to remain dynamic over the forecast period, as players continue to invest in research and development and seek opportunities for growth.One of the leading companies in the Automated And Closed Cell Therapy Processing System Market is Terumo BCT. The company offers a comprehensive range of automated and closed cell therapy processing systems, including the Spectra Optia and Quantum systems. Terumo BCT has a strong global presence and is continuously expanding its operations through strategic partnerships and acquisitions. The company is committed to providing innovative solutions that improve the safety and efficiency of cell therapy processing.A competitor company in the Automated And Closed Cell Therapy Processing System Market is Fresenius Kabi. The company offers a range of automated cell processing systems, including the Sepax and Cryostar systems. Fresenius Kabi has a strong focus on research and development and is constantly innovating to meet the evolving needs of the cell therapy industry. The company has a global presence and is committed to providing high-quality products and services to its customers.

Key Companies in the Automated And Closed Cell Therapy Processing System Market Include:

• Cytiva


• Sartorius


• Terumo BCT


• Macopharma


• Cellectis


• Lonza


• HemaCare


• GE Healthcare


• Miltenyi Biotec


• Fresenius Kabi


• Kite Pharma


• Roche


• Thermo Fisher Scientific


• Novartis


• Autolus Therapeutics

Automated And Closed Cell Therapy Processing System Market Industry Developments

The Automated And Closed Cell Therapy Processing System Market size was valued at USD 1.04 billion in 2023 and is projected to expand at a CAGR of 10.29% over the forecast period, reaching USD 2.5 billion by 2032. This growth is attributed to the increasing prevalence of cancer and other chronic diseases, along with the rising demand for personalized and targeted therapies.Recent news developments include: In February 2023, GE Healthcare launched the latest version of its FlexFactory platform, designed for automated cell therapy manufacturing. In March 2023, Miltenyi Biotec announced a partnership with Thermo Fisher Scientific to develop and commercialize a closed-system cell therapy manufacturing platform.These advancements demonstrate the growing interest and investment in automated and closed cell therapy processing systems as the industry seeks to improve efficiency, safety, and accessibility of cell-based therapies.

Automated And Closed Cell Therapy Processing System Market Segmentation Insights

• Automated And Closed Cell Therapy Processing System Market Cell Therapy Outlook


• CAR T-Cell Therapies


• TCR Gene-Edited Cell Therapies


• NK Cell Therapies

• Automated And Closed Cell Therapy Processing System Market Application Outlook


• Oncology


• Hematology


• Immunology


• Neurology

• Automated And Closed Cell Therapy Processing System Market System Capability Outlook


• Single-Use


• Multi-Use


• Closed


• Semi-Closed


• Open

• Automated And Closed Cell Therapy Processing System Market Scale of Production Outlook


• Benchtop


• Pilot Scale


• Commercial Scale

• Automated And Closed Cell Therapy Processing System Market Device Type Outlook


• Cell Isolators


• Cell Expanders


• Cell Culture Vessels


• Cell Dispensers

• Automated And Closed Cell Therapy Processing System Market Regional Outlook


• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa